Top compounds associated with response to AL109923.1


Feature Type Standardized
Nominal ANOVA
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.39 0.0008
mRNA PF-3758309 CTRPv2 pan-cancer AAC -0.15 0.0008
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.002
mRNA etoposide CTRPv2 pan-cancer AAC -0.09 0.003
mRNA Topotecan CTRPv2 pan-cancer AAC -0.096 0.003
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.13 0.004
mRNA oligomycin a CTRPv2 pan-cancer AAC -0.11 0.004
mRNA CI-976 CTRPv2 pan-cancer AAC -0.11 0.005
Download CSV